Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Barriers to Radiation-Induced In Situ Tumor Vaccination
Erik Wennerberg, Claire Lhuillier, Claire Vanpouille‐Box, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 420
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Abhishek D. Garg, Patrizia Agostinis
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 126-148
Open Access | Times Cited: 374
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Abhishek D. Garg, Sanket More, Nicole Rufo, et al.
OncoImmunology (2017) Vol. 6, Iss. 12, pp. e1386829-e1386829
Open Access | Times Cited: 241
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Hanne Locy, Sven de Mey, Wout de Mey, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 214
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 194
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Diana Klein
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 173
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
Ravi Patel, Reinier Hernandez, Peter M. Carlson, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 602
Open Access | Times Cited: 155
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
Maxim Shevtsov, Hiro Sato, Gabriele Multhoff, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 148
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
NE Donlon, Robert Power, Conall Hayes, et al.
Cancer Letters (2021) Vol. 502, pp. 84-96
Open Access | Times Cited: 130
Interfering with Tumor Hypoxia for Radiotherapy Optimization
Irma Telarović, Roland H. Wenger, Martin Pruschy
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 113
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
Cheng‐En Hsieh, Sunil Krishnan, Ren‐Chin Wu, et al.
Science Immunology (2022) Vol. 7, Iss. 72
Open Access | Times Cited: 95
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Immunomodulation by ionizing radiation—impact for design of radio‐immunotherapies and for treatment of inflammatory diseases
Benjamin Frey, Michael Rückert, Lisa Deloch, et al.
Immunological Reviews (2017) Vol. 280, Iss. 1, pp. 231-248
Closed Access | Times Cited: 159
Role of the immunosuppressive microenvironment in immunotherapy
Garth W. Tormoen, Marka R. Crittenden, Michael J. Gough
Advances in Radiation Oncology (2018) Vol. 3, Iss. 4, pp. 520-526
Open Access | Times Cited: 150
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1511506-e1511506
Open Access | Times Cited: 144
Immune targets in the tumor microenvironment treated by radiotherapy
Omer M. Ozpiskin, Lu Zhang, Jian Jian Li
Theranostics (2019) Vol. 9, Iss. 5, pp. 1215-1231
Open Access | Times Cited: 128
Targeted and Off-Target (Bystander and Abscopal) Effects of Radiation Therapy: Redox Mechanisms and Risk/Benefit Analysis
Jean‐Pierre Pouget, Alexandros G. Georgakilas, Jean‐Luc Ravanat
Antioxidants and Redox Signaling (2018) Vol. 29, Iss. 15, pp. 1447-1487
Open Access | Times Cited: 126
Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
Florian Wirsdörfer, Simone de Leve, Verena Jendrossek
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 24-24
Open Access | Times Cited: 125
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
Aitziber Buqué, Norma Bloy, Fernando Aranda, et al.
OncoImmunology (2015) Vol. 4, Iss. 4, pp. e1008814-e1008814
Open Access | Times Cited: 121
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection
Erik Wennerberg, Sheila Spada, Nils-Petter Rudqvist, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 4, pp. 465-478
Open Access | Times Cited: 107
Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment
Laurel B. Darragh, Ayman Oweida, Sana D. Karam
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 106
The abscopal effect 67 years later: from a side story to center stage
Sandra Demaria, Silvia C. Formenti
British Journal of Radiology (2020) Vol. 93, Iss. 1109
Open Access | Times Cited: 102
Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
Michael Rückert, Lisa Deloch, Rainer Fietkau, et al.
Strahlentherapie und Onkologie (2018) Vol. 194, Iss. 6, pp. 509-519
Closed Access | Times Cited: 100
Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
Shweta Joshi, Donald L. Durden
Journal of Oncology (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 98
In vivo magnetic nanoparticle hyperthermia: a review on preclinical studies, low-field nano-heaters, noninvasive thermometry and computer simulations for treatment planning
Harley F. Rodrigues, Gustavo Capistrano, Andris F. Bakuzis
International Journal of Hyperthermia (2020) Vol. 37, Iss. 3, pp. 76-99
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top